Peter van Harten
Peter van Harten
Hoogleraar psychiatrie, Universiteit van Maastricht
Verified email at - Homepage
Cited by
Cited by
The five-factor model of the Positive and Negative Syndrome Scale II: a ten-fold cross-validation of a revised model
M van der Gaag, T Hoffman, M Remijsen, R Hijman, L de Haan, ...
Schizophrenia research 85 (1-3), 280-287, 2006
Acute dystonia induced by drug treatment
PN van Harten, HW Hoek, RS Kahn
Bmj 319 (7210), 623-626, 1999
The five-factor model of the Positive and Negative Syndrome Scale I: confirmatory factor analysis fails to confirm 25 published five-factor solutions
M van der Gaag, A Cuijpers, T Hoffman, M Remijsen, R Hijman, ...
Schizophrenia research 85 (1-3), 273-279, 2006
Antipsychotic-induced tardive dyskinesia and polymorphic variations in COMT, DRD2, CYP1A2 and MnSOD genes: a meta-analysis of pharmacogenetic interactions
PR Bakker, PN Van Harten, J Van Os
Molecular psychiatry 13 (5), 544-556, 2008
The incidence of anorexia nervosa on Curacao
HW Hoek, PN van Harten, KME Hermans, MA Katzman, GE Matroos, ...
American Journal of Psychiatry 162 (4), 748-752, 2005
Antipsychotic-induced tardive dyskinesia and the Ser9Gly polymorphism in the DRD3 gene: a meta analysis
PR Bakker, PN van Harten, J van Os
Schizophrenia research 83 (2-3), 185-192, 2006
The prevalence of tardive dystonia, tardive dyskinesia, parkinsonism and akathisia The Curacao Extrapyramidal Syndromes Study: I
PN van Harten, GE Matroos, HW Hoek, RS Kahn
Schizophrenia research 19 (2-3), 195-203, 1996
Dyskinesia and parkinsonism in antipsychotic-naive patients with schizophrenia, first-degree relatives and healthy controls: a meta-analysis
JPF Koning, DE Tenback, J van Os, A Aleman, RS Kahn, PN van Harten
Schizophrenia bulletin 36 (4), 723-731, 2010
Antipsychotic medication in children and adolescents: a descriptive review of the effects on prolactin level and associated side effects
Y Roke, PN van Harten, AM Boot, JK Buitelaar
Journal of child and adolescent psychopharmacology 19 (4), 403-414, 2009
Tardive dystonia
PN van Harten, RS Kahn
Schizophrenia bulletin 25 (4), 741-748, 1999
Evidence that early extrapyramidal symptoms predict later tardive dyskinesia: a prospective analysis of 10,000 patients in the European Schizophrenia Outpatient Health Outcomes …
DE Tenback, PN Van Harten, CJ Slooff, J Van Os, SOHO Study Group
American Journal of Psychiatry 163 (8), 1438-1440, 2006
Intermittent neuroleptic treatment and risk for tardive dyskinesia: Curacao Extrapyramidal Syndromes Study III
PN van Harten, HW Hoek, GE Matroos, M Koeter, RS Kahn
American Journal of Psychiatry 155 (4), 565-567, 1998
Simultaneous prescribing of atypical antipsychotics, conventional antipsychotics and anticholinergics—a European study
WJ Broekema, IW De Groot, PN Van Harten
Pharmacy world & science 29, 126-130, 2007
The clinical and prognostic value of motor abnormalities in psychosis, and the importance of instrumental assessment
PN van Harten, S Walther, JS Kent, SR Sponheim, VA Mittal
Neuroscience & Biobehavioral Reviews 80, 476-487, 2017
Effects of antipsychotic treatment on tardive dyskinesia: a 6-month evaluation of patients from the European Schizophrenia Outpatient Health Outcomes (SOHO) Study
DE Tenback, PN van Harten, CJ Slooff, MA Belger, J van Os
Journal of Clinical Psychiatry 66 (9), 1130-1133, 2005
Non‐therapeutic risk factors for onset of tardive dyskinesia in schizophrenia: a meta‐analysis
DE Tenback, PN van Harten, J van Os
Movement disorders 24 (16), 2309-2315, 2009
Cocaine as a risk factor for neuroleptic-induced acute dystonia
PN Van Harten, J Van Trier, EH Horwitz, GE Matroos, HW Hoek
Journal of Clinical Psychiatry 59 (3), 128-130, 1998
Long-stay psychiatric patients: a prospective study revealing persistent antipsychotic-induced movement disorder
PR Bakker, IW de Groot, J van Os, PN van Harten
PloS one 6 (10), e25588, 2011
Addition of risperidone to clozapine therapy in chronically psychotic inpatients.
IW de Groot, AH Heck, PN van Harten
Physicians Postgraduate Press, 2001
Meta-analysis of probability estimates of worldwide variation of CYP2D6 and CYP2C19
AB Koopmans, MH Braakman, DJ Vinkers, HW Hoek, PN van Harten
Translational psychiatry 11 (1), 141, 2021
The system can't perform the operation now. Try again later.
Articles 1–20